![Michael Woolliscroft](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Woolliscroft
Keine laufenden Positionen mehr
Karriereverlauf von Michael Woolliscroft
Ehemalige bekannte Positionen von Michael Woolliscroft
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SIERRA ONCOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.01.2014 | - |
Corporate Officer/Principal | - | 28.01.2014 |
Ausbildung von Michael Woolliscroft
University of Michigan | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Sierra Oncology, Inc.
![]() Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
- Börse
- Insiders
- Michael Woolliscroft
- Erfahrung